OHSU study advances understanding of TDP-43 protein in ALS
Dennis Hazelett, Ph.D., a postdoctoral fellow in the Morton Lab, is lead author on the paper.
A new study by researchers at the OHSU School of Dentistry advances our understanding of how a protein, TDP-43, impacts gene expression in neurodegenerative diseases like ALS. The researchers altered levels of TDP-43 in fruit flies to directly compare too much versus too little of the protein. Using massively parallel sequencing, they found that loss of TDP-43 results in widespread gene activation and altered splicing. Over expression resulted in decreased gene expression–a finding contrary to previous studies that indicated both loss-of-function and over expression may cause ALS.
For more information, check out the OHSU News release, or read the full paper, published this month in G3: Genes, Genomes, Genetics.
This study was supported by grants from the National Institutes of Health (NS071186); the ALS Association; and the Muscular Dystrophy Association.
Recent Comments
- Quen on Phillip Marucha, D.M.D., Ph.D., is new School of Dentistry dean
- Sandy Pierce on Doernbecher researchers first to grow transplantable liver stem cells in culture
- Susan Oliver on 125th lecture series: Eric Dishman on accelerating personal health, April 1
More Comments